Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 16Uterine Cervical Neoplasms 5Stomach Neoplasms 5Lung Neoplasms 5Carcinoma, Transitional Cell 5Carcinoma, Hepatocellular 5Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Prostatic Neoplasms 4Ovarian Neoplasms 4Oropharyngeal Neoplasms 4Esophageal Neoplasms 4Cholangiocarcinoma 4Urinary Bladder Neoplasms 3Thyroid Neoplasms 3Neuroendocrine Tumors 3Neoplasm Metastasis 3Multiple Myeloma 3Lymphoma, Large B-Cell, Diffuse 3Anus Neoplasms 3Testicular Neoplasms 2Solid Tumor 2Pheochromocytoma 2Paraganglioma 2Pancreatic Neoplasms 2Neoplasms 2Mouth Neoplasms 2Melanoma 2Leukemia, Myeloid, Acute 2Laryngeal Neoplasms 2

Interventions

durvalumab 13Bevacizumab 11Nivolumab 10tremelimumab 7pembrolizumab 6lenvatinib 6fludarabine 6Cyclophosphamide 6atezolizumab 4Radiosurgery 4Cisplatin 4toripalimab 3relatlimab 3Magnetic Resonance Imaging 3Ipilimumab 3Gemcitabine 3X-Rays 2Standard of Care 2Sorafenib 2Riluzole 2Radiotherapy 2Photons 2Patient Navigation 2Lidocaine 2Hepatectomy 2Dexamethasone 2Biopsy 2trastuzumab deruxtecan 1tocilizumab 1tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Neoplasms × Fluorodeoxyglucose F18 × 1 year × Clear all
NCT05009979 2025-08-28

18F-DCFPyL PET/CT in Hepatocellular Carcinoma

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
8 enrolled 14 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡